期刊文献+

多囊卵巢综合征患者体外受精或卵细胞质内单精子注射的不同超促排卵方案比较 被引量:1

Comparison of different superovulation protocols for in vitro fertilization or intra cytoplasmic sperm injection in patients with polycystic ovary syndrome
下载PDF
导出
摘要 目的:探讨黄体期短效促性腺激素释放激素激动剂(gonadotropin releasing hormone agonist,GnRH-a)长方案、卵泡期GnRH-a长方案以及促性腺激素释放激素拮抗剂(gonadotropin releasing hormone antagonist,GnRH-ant)方案3种超促排卵方案在进行体外受精或卵细胞质内单精子注射-胚胎移植(in vitro fertilization/intra cytoplasmic sperm injection and embryo transfer,IVF/ICSI-ET)治疗的多囊卵巢综合征(polycystic ovary syndrome,PCOS)患者中的应用价值。方法:回顾性分析2017年1月—2020年12月在汕头大学医学院第一附属医院接受IVF/ICSI-ET治疗的PCOS患者293个周期的临床资料,根据超促排卵方案分为黄体期短效GnRH-a长方案组(A组,48个取卵周期),卵泡期GnRH-a长方案组(B组,108个取卵周期),GnRH-ant方案组(C组,137个取卵周期)。分析3组患者的超促排卵情况以及临床治疗结局。结果:B组和C组的促性腺激素(gonadotropin,Gn)启动量低于A组(P值均<0.05);C组的Gn使用时间最短、Gn使用总量最少(P值均<0.05);B组人绒毛膜促性腺激素(human chorionic gonadotropin,HCG)注射日的血清雌二醇水平低于A组和C组(P值均<0.05);C组HCG注射日的内膜厚度低于A组和B组(P值均<0.05)。3组的获卵数、可利用胚胎数、优胚率、移植胚胎数、临床妊娠率、胚胎种植率、早期流产率、异位妊娠率、中重度卵巢过度刺激综合征发生率、全胚冷冻率及活产率差异无统计学意义(P值均>0.05)。结论:GnRH-ant方案具有总Gn用量少、Gn刺激时间短等优势。 Objective: To investigate the effects of three superovulation protocols of luteal phase short-acting gonadotropin releasing hormone(GnRH) agonist long-term protocol, follicular phase GnRH agonist long-term protocol, and GnRH antagonist protocol in patients with polycystic ovary syndrome(PCOS) treated with in vitro fertilization or intra cytoplasmic sperm injection and embryo transfer(IVF/ICSI-ET). Methods: The clinical data of 293 cycles of PCOS patients who received IVF/ICSI-ET in the First Affiliated Hospital of Shantou University Medical College from January 2017 to December 2020 were retrospectively analyzed. The patients were divided into luteal phase short-acting GnRH agonist long-term protocol group(group A, 48 cycles), follicular phase GnRH agonist long-term protocol group(group B, 108 cycles), and GnRH antagonist protocol group(group C, 137 cycles)according to the superovulation protocols. The superovulation conditions and clinical treatment outcomes of the three groups of patients were analyzed. Results: The starting amount of gonadotropin(Gn) in groups B and C was lower than that in group A(all P<0.05);group C had the shortest use time of Gn and the least total amount of Gn(all P<0.05);the level of estradiol on the day of human chorionic gonadotropin(HCG) injection in group B was lower than that in groups A and C(both P<0.05);the endometrial thickness of group C on the day of HCG injection was lower than that in groups A and B(both P<0.05). There was no significant difference in the number of oocytes retrieved, the number of available embryos, the rate of good quality embryos, the number of transferred embryos,the clinical pregnancy rate, the embryo implantation rate, the early abortion rate, the ectopic pregnancy rate, the incidence of moderate to severe ovarian hyperstimulation syndrome, whole embryo freezing rate and live birth rate in the three groups(all P>0.05). Conclusion: The GnRH antagonist protocol has the advantages of less total Gn dosage and shorter Gn stimulation time.
作者 陈曼 林虹 夏汝斌 彭三凤 李志凌 CHEN Man;LIN Hong;XIA Rubin;PENG Sanfeng;LI Zhiling(Department of Reproductive Medicine,the First Affiliated Hospital of Shantou University Medical College,Shantou 515041,China)
出处 《汕头大学医学院学报》 2022年第2期86-91,共6页 Journal of Shantou University Medical College
基金 汕头市医疗卫生科技计划项目(汕府科[2019]70号-9)。
关键词 多囊卵巢综合征 体外受精胚胎移植术 卵细胞质内单精子注射 超促排卵 polycystic ovary syndrome in vitro fertilization and embryo transfer intra cytoplasmic sperm injection superovulation
  • 相关文献

参考文献7

二级参考文献55

  • 1Escudero E, Bosch E, Crespo J, et al. Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients[J]. Fertil Steril, 2004, 81 (3):562-566.
  • 2Oberye J J, Mannaerts BM, Huisman JA, et al. Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers[J]. Fertil Steril, 1999, 72(6):1006-1012.
  • 3Huirne JA, Lambalk CB. Gonadotropin-releasing-hormone- receptor antagonists[J]. Laneet, 2001, 358(9295):1793-1803.
  • 4Copperman AB, Benadiva C. Optimal usage of the GnRH antagonists: a review of the literature[J]. Reprod Biol Endoerinol, 2013, 11:20.
  • 5Al-Inany HG, Youssef MA, Aboulghar M, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology[J]. Cochrane Database Syst Rev, 2011(5):CD001750.
  • 6Qiao J, Lu G, Zhang HW, et al. A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates[J]. Gynecol Endocrinol, 2012, 28(10):800-804.
  • 7Marei R, Caserta D, Lisi F, et al. In vitro fertilizationstimulationprotocol for normal responder patients [J]. Gynecol Endocrinol, 2013, 29(2): 109-112.
  • 8Griesinger G, Diedrich K, Tarlatzis BC, et al. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis[J]. Reprod Biomed Online, 2006, 13(5): 628-638.
  • 9Pundir J, Sunkara SK, E1-Toukhy T, et al. Meta-analysis ofGnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?[J]. Reprod Biomed Online, 2012, 24(1):6-22.
  • 10Xiao J, Chen S, Zhang C, et al. Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis[J]. Gynecol Endocrinol, 2013, 29(3): 187-191.

共引文献331

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部